Santhera and ReveraGen Announce Successful FDA Pre-NDA Meeting for Vamorolone in Duchenne Muscular Dystrophy

NEXT STORY
Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer
PREV STORY
Zentek Announces C$20 Million Bought Deal Public Offering and C$12.5 Million Non-Brokered Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science to present at two upcoming conferences in September 2019, the NewsMakers 2019 Healthcare conference and the H.C. Wainwright Healthcare Conference

author_avatar
NASDAQ Market News

‘When seconds count’: Maryland’s statewide emergency medical services communications system to benefit from major technology upgrade

Overland Contracting, Inc., to oversee project that will retire legacy technologies and improve network ...

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals Presents Final Updated Phase 1b Results for TRC105 in Combination with Inlyta® in Renal Cell Carcinoma at the ESMO 2016 Congress

SAN DIEGO, Oct. 09, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...

author_avatar
NASDAQ Market News